Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Exclusive: Biotech investor Sofinnova hires former Biogen medical chief
9 months ago
Bristol Myers to cut more jobs at headquarters as part of announced restructure
9 months ago
Pharma
Q&A: Genentech's new CEO on AI, IRA and radiopharma
9 months ago
R&D
AI
Florida CNS gene therapy biotech shuts down
9 months ago
Startups
Cell/Gene Tx
PARP biotech backed by more than five pharmas closes after nine years
9 months ago
Startups
Former RayzeBio CEO quickly returns with new biotech; Amgen’s global research leader steps down
9 months ago
Peer Review
Despite recent trial success, uniQure plans to cut 65% of staff
9 months ago
Pharma
Arbutus reduces headcount after axing HBV combo trial that features Imfinzi
9 months ago
R&D
Updated: Jim Wilson to step down from gene therapy post at UPenn, will form two new companies
9 months ago
R&D
Cell/Gene Tx
After norovirus vaccine's trial failure, HilleVax lays off 40% of staff
9 months ago
FibroGen to shrink US workforce by 75% following more late-stage fails
9 months ago
R&D
Bessemer VC Morgan Cheatham shares how AI healthcare startups can win in a crowded market
9 months ago
AI
Health Tech
Roivant's dealmaker lands $81M cash bonus following drug sale to Roche
9 months ago
Pfizer cuts 210 North Carolina workers after it officially discontinues failed Duchenne gene therapy
9 months ago
Cell/Gene Tx
Manufacturing
Andrew Left, short seller who campaigned against Valeant, is accused of fraud by SEC
9 months ago
Pharma
Law
Cue Biopharma prioritizes autoimmune pipeline, axes a quarter of staff to save cash
9 months ago
R&D
Manatt scoops up health tech experts Christina Farr and Tom Cassels
9 months ago
Health Tech
Exclusive: After selling Mirati to BMS for nearly $5B, Chuck Baum lands at another ‘undruggable’ company
9 months ago
Bob Langer, Flagship's Stephen Berenson to depart Moderna's board as Carlyle co-founder joins
9 months ago
Sino Biopharm's invoX to restructure, likely cutting about 60 roles
9 months ago
Layoffs at Rapt Therapeutics after winding down mid-stage trials of lead drug
9 months ago
Nadir Mahmood returns to Nkarta a year after leaving; BeiGene picks longtime Merck exec for CFO post
9 months ago
Peer Review
Gilead chief medical officer Merdad Parsey to leave company early next year
9 months ago
R&D
Cassava founder and CEO resigns as federal probes progress
9 months ago
First page
Previous page
7
8
9
10
11
12
13
Next page
Last page